![]() Decibel Therapeutics Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance. | HDL Therapeutics HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis. | ![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | |||
Founding Date | Founding Date 2002 | Founding Date 2015 | Founding Date N/A | Founding Date 2009 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations San Carlos, US HQ | Locations Boston, US HQ | Locations Dublin, IE HQ Dublin, IE | Locations Vero Beach, US HQ | Locations San Clemente, US HQ San Clemente, US |
Employees | Employees 2713% increase | Employees 6810% increase | Employees 838% increase | Employees 7 | Employees 4348% decrease |
Valuation ($) | Valuation ($) 8.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3 m |
Financial | |||||
Net income | Net income ($8.2m) (FY, 2025) | Net income ($63m) (FY, 2022) | Net income N/A | Net income N/A | Net income ($21.6m) (FY, 2020) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7.5m (about 10 years ago) | Latest funding round $ 3m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 189m | Total funding raised $ 7.5m | Total funding raised $ 7.4m | Total funding raised N/A |

Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.
View company
FIRE1 focuses on developing novel remote monitoring devices.
View companyHDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis.
View company
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company